Lv2
180 积分 2023-09-15 加入
Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease
1个月前
已完结
Integrative multi-omics unravels the amelioration effects of Zanthoxylum bungeanum Maxim. on non-alcoholic fatty liver disease
1个月前
已完结
PPAR control of metabolism and cardiovascular functions
5个月前
已完结
Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression
5个月前
已完结
Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
5个月前
已完结
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
5个月前
已完结
NASH drug treatment development: challenges and lessons
5个月前
已完结
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
5个月前
已完结
NASH drug treatment development: challenges and lessons
5个月前
已完结
Can we use old NAFLD data under the new MASLD definition?
5个月前
已完结
皖公网安备34019202002308
